The MLR in the non-remission group was higher than that in the remission group; however, the difference between the two groups did not reach statistical significance [median 0.27 (IQR 0.22–0.37) versus 0.24 (0.19–0.34), P = .091] (Table 1 ).
← all excerpts
Systemic inflammation and B cell indices predict rituximab responses in membranous nephropathy.
1
0.0910
0.0910